Joseph Miller

Director of Finance/CFO presso AURINIA PHARMACEUTICALS INC.

Patrimonio netto: 2 M $ in data 31/03/2024

50 anni

Health Technology

Commercial Services

Consumer Services

Posizioni attive di Joseph Miller

Società	Posizione	Inizio	Fine
AURINIA PHARMACEUTICALS INC.	Director of Finance/CFO	27/04/2020	-

Società	Posizione	Inizio	Fine
AVALO THERAPEUTICS, INC.	Director/Board Member	24/04/2020	01/06/2022
	Director of Finance/CFO	12/07/2018	24/04/2020
	Corporate Secretary	-	24/04/2020
SUCAMPO PHARMACEUTICALS, INC.	Director of Finance/CFO	01/01/2015	01/04/2018
Qiagen Genomics, Inc. Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen Genomics, Inc. provides research and technology in the bioscience area. The company is headquartered in Bothell, WA.	Comptroller/Controller/Auditor	01/01/2006	01/01/2015
Eppendorf-5 Prime, Inc.	Director of Finance/CFO	01/01/2002	01/01/2006

Villanova University

Undergraduate Degree

Distribuzione geografica

Stati Uniti	6
Canada	2

Posizioni

Settori

Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Società quotate in Borsa	2
AVALO THERAPEUTICS, INC.	Health Technology
AURINIA PHARMACEUTICALS INC.	Health Technology

Aziende private	3
Qiagen Genomics, Inc. Qiagen Genomics, Inc. Miscellaneous Commercial ServicesCommercial Services Qiagen Genomics, Inc. provides research and technology in the bioscience area. The company is headquartered in Bothell, WA.	Commercial Services
Sucampo Pharmaceuticals, Inc. Sucampo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Sucampo Pharmaceuticals, Inc. is a biopharmaceutical company. It engages in the development, identification, acquisition, and delivery of innovative pharmaceutical products. The company was founded by Ryuji Ueno and Sachiko Kuno on December 5, 1996 and is headquartered in Bethesda, MD.	Health Technology
Eppendorf-5 Prime, Inc.